Top 5 Puzzle RPG Apps in Greece: Q2 2022 Performance Overview

In Q2 2022, the top 5 Puzzle RPG applications in Greece showcased varied performance trends across weekly downloads, revenue, and active users. Here’s an overview of their performance:

Empires & Puzzles: Match-3 RPG from Small Giant Games experienced fluctuations in weekly revenue, peaking at approximately $55K in the last week of May. Weekly downloads saw a gradual increase, starting at 534 and reaching 1.1K by the end of June. Meanwhile, weekly active users showed a steady rise, maintaining around 10.5K to 11.4K throughout the quarter.

MythWars & Puzzles: RPG Match3 by Karmagame HK Limited had consistent weekly revenue, with a notable increase to $3K in the final week of June. Weekly downloads fluctuated, starting at 268 and declining to 227 by the end of the quarter. Active users varied slightly, peaking at 4.8K in early May before dropping to 3.6K in late June.

DRAGON BALL Z DOKKAN BATTLE from Bandai Namco Entertainment Inc. saw a sharp decline in weekly revenue, starting at $3.5K and falling to $960 by the end of June. Weekly downloads remained relatively stable, ranging from 180 to 382. Active users increased steadily, peaking at 918 in the last week of June.

Call of Antia: Match 3 RPG by FunPlus International AG had a mixed performance in weekly revenue, with a significant spike to $3K in the last week of May. Weekly downloads were low but saw an increase from 88 in early May to 213 by the end of June. Active users showed a slight upward trend, peaking at 997 in late May before stabilizing around 788 by the end of June.

Puzzles & Survival from 37GAMES had consistent weekly revenue, peaking at $1.4K in mid-April. Weekly downloads were relatively low, with a peak of 522 in early May before dropping to 145 by the end of June. Active users saw fluctuations, peaking at 1.8K in early May before stabilizing around 1.4K by the end of June.

These insights are based on data from Sensor Tower. For more detailed analytics and trends, visit Sensor Tower.